SARS-CoV-2 Induced Interleukin -18 Response among Presumptive Covid-19 Patients in Kano State, Nigeria
DOI:
https://doi.org/10.47430/ujmr.2493.032Keywords:
Biomarker, COVID-19, Interleukin-18, Kano, SARS-CoV-2Abstract
Study’s Novelty/Excerpt
- This study evaluates Interleukin-18 (IL-18) as a potential biomarker for COVID-19 by comparing its serum levels in COVID-19-positive patients and healthy controls.
- The research uniquely identifies significantly elevated IL-18 levels in COVID-19 patients, demonstrating a strong statistical association with the infection (t value 6.16, p <0.00010).
- These findings underscore the potential of IL-18 in the prognosis and clinical management of COVID-19, offering new insights into its role in the disease's pathophysiology and its utility as a biomarker.
Full Abstract
Coronaviruses have a history of causing severe outbreaks with life-threatening consequences, including Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and the recent coronavirus disease 2019 (COVID-19). COVID-19 first broke out in Wuhan (China) in December 2019). The disease was later declared a pandemic, and so far, more than 222 countries have been affected, with over 771 million confirmed cases and total deaths of over 7.05 million. Some immunological markers were reported elsewhere as directly related to COVID-19 pathophysiology and stand a chance to be considered biomarkers. Interleukin 18 (IL-18) is a proinflammatory cytokine and a member of the interleukin-1 family, produced by macrophages at the early stage of viral infections. However, aberrant IL-18 production can lead to severe pathological injury. Hence, there is a need to assess the feasibility of interleukin -18 as a biomarker for COVID-19. Forty-five individuals diagnosed with COVID-19 and 45 healthy controls screened using a COVID-19 antigen rapid test kit and confirmed by one-step real-time PCR were recruited for this study. Blood samples were collected from the patients and controls, and the samples were analyzed for IL-18 using the ELISA technique. This study revealed a higher level of IL-18 in COVID-19-positive patients (206.42 ± 13.2 pg/mL) compared to the control group (97.96 ± 14.4 pg/mL). Serum level IL-18 was statistically associated with COVID-19 infection (t value 6.16, p <0.00010). The study demonstrates the importance of IL-18 in the COVID-19 cohort, inferentially implying its potential in the prognosis and clinical management of COVID-19.
Downloads
References
Afrah, A. H., and Abdelhameed, A. M. (2022). High Interleukin-18 Could be Associated with Severe Disease in COVID-19 Patients.World Bulleting of Public Health, 10, 2749– 3644.
Bowale, A., Abayomi, A., Idris, J., Omilabu, S., Abddul-salam, I., Adebayo, B.,…Osibogun, A. (2020). Clinical Presentation case Management and Outcomes for the first 32 COVID-19 Patients in Nigeria, The pan African Medical Journal, 35(2), 24. https://doi.org/10.11604/pamj.supp.2020.35.2.23262
Bwire, G. M. (2020). Coronavirus Why Men are more Vulnerable to COVID-19 than Women, Comprehensive Clinical Medicine, 2(7), 874-876. https://doi.org/10.1007/s42399-020-00341-w
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F. and Han, Y. (2020). Epiemiological and Clinical Characteristics of 99 cases of 2019 novel Coronavirus Pneumonia in Wuhan, Lancet. 395 (10223), 507-13. https://doi.org/10.1016/S0140-6736(20)30211-7
El-Sagheer, N. A., Gomaa, A., Alshawaraway, L. A. and Abdel-Aziz, M. A. (2022). Prognostic Value of IL-18 Serum levels in COVID-19 Patients at Beni-suef University hospital, Egyptian Journal of Medical Research, 3(3). https://doi.org/10.21608/ejmr.2022.259009
Fouda, E.M., Nancy, S.W, Asmaa, I.M., Elsharawy, M. B., Sally, R. and Ishak, M. D. (2021). Serum Homocysteine level in Pediatric Patients with COVID-19 and its Correlation with the Disease Severity, Journal of Pediatric Pulmonology, 57(7):1701– 1708. https://doi.org/10.1002/ppul.25920
Guan, W. J., Ni, Z. Y., Liang, W. H., Ou, C. Q., He, J. X., Lei, L.,…Zhong, N. S. (2020). Clinical Characteristics of Coronavirus Disease, New England journal of medicine, 38(2),1708-1720. https://doi.org/10.1056/NEJMoa2002032
Guo, H., Chi, J., Xing, Y. and Wang, P. (2009). Influence of Folic acid on Plasma Homocysteine levels & Arterial Endothelial Function in Patients with Unstable Angina. Indian Journal of Medical Research, 129(3), 279–84.
Hennekens, C. H. V Buring, J. E. (1987). Epidemiology in Medicine. American Journal of Epidemiology, 1-383.
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R. and Vincent, J. L. (2016). Sepsis and Septic shock. Nature Reviews Disease Primers, 2(1), 1-2. https://doi.org/10.1038/nrdp.2016.45
Jibrin, Y. B., Okwong, O. K., Maigari, I. M.,Dunga, J. B., Ballah, A. B., Umar, M.S.,… Hassan, Z. I. (2020). Clinical and Laboratory Characteristics of COVID-19Among Adult Patients Admitted to the Isolation Centre at Abubakar Tafawa Balewa Teaching Hospitals Bauchi, Northeast Nigeria, Pan African Medical Journal, 37(1),27. https://doi.org/10.11604/pamj.supp.2020.37.1.26162
Kaplansk, G. (2018). Interleukin-18, Biological Properties and Role in Disease Pathogenesis. Immunology Review, 281(1), 138-53. https://doi.org/10.1111/imr.12616
Kerget, B., Kerget, F., Aksakal, A., Aşkın, S., Sağlam, L. and Akgün, M. (2021). Evaluation of alpha Defensin in IL‐1receptor Antagonist and IL‐18 Levels in COVID‐19 Patients with Macrophage Activation Syndrome and Acute Respiratory Distress Syndrome. Journal of Medical Virology, 93(4), 20. https://doi.org/10.1002/jmv.26589
Khalid, A., Ali, S., Khan, T., Lail, R. A., Jaffar, M. A., Aktas, G., Abdulwaris. Javaid, A., Ijaz, M. and Muhammad, N. (2021). Hematological and Biochemical Parameters as Diagnostic and Prognostic Markers in SARS-COV-2 Infected Patients of Pakistan.Journal of Haematology, 26(1), 52 9–542. https://doi.org/10.1080/16078454.2021.1950898
Kurawa, A. (2006). Geographical and history of Kano state in three years of good governance shekarau’ Stewardship in Kano state, research and documentation government house Kano.6.
Lagunas-Range, F. A. and Chávez-Valencia, V. (2020).IL-6/IFN-γ ratio could be Associated with Severe Disease in COVID-19 Patients, Journal of Medical Virology, 92(10), 1789-1790. https://doi.org/10.1002/jmv.25900
Lan, L., Xu, D., Ye, G., Xia, C., Wang, S., Li, Y. and Xu, H. (2020). Positive RT-PCR test results in Patients Recovered from COVID-19, JAMA, 323(15):1502-1503. https://doi.org/10.1001/jama.2020.2783
Mardani, R., Namavar, M., Ghorbi, E., Shoja, Z., Zali, F., Kaghazian, H.,… Mousavi-Nasab, S.D. (2020). Association Serum Inflammatory Parameters and the Disease Severity in COVID-19 Patients, Journal of Clinical Laboratory Analysis, 36(1):24162. https://doi.org/10.1002/jcla.24162
National Population Commission (2009). Population and Housing Cencus of the Federal Republic of Nigeria Priority Tables (Volume I): National and State Population and Housing Tables http://www.population.gov.ng/index.php/publications/136-housingcharasteristics-and-Amenities. Assessed 16th march, 2020.
Nigeria Centre for Disease Control and Prevention. (2023). Official Statement on the new COVID-19 Subvariants. Retrieved from NCDC
Olayanju, O., Edem, F., Eseile, B., Amoo, a., Nwaokenye J., Udeh, C., Ouwole. G., Odok, G. and Awah, N. (2021). SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria. The American Journal of Tropical Medicine and Hygeine, 104 (1), 91-1235. https://doi.org/10.4269/ajtmh.20-1235
Otuonye, N. M., Olumade, T. J., Oyetunde, M. M., Holdbrooke, S. A., Ayoola, J. B., Nyam, I. Y.,... Odunukwe, N. N. (2021). Clinical and Demographic Characteristics of COVID-19 Patients in Lagos, Nigeria, A Descriptive Study.Journal of the National Medical Association, 113(3), 301-306. https://doi.org/10.1016/j.jnma.2020.11.011
Rodrigues, T. S., Keyla, S. G., shimoto, A., Amanda, B. and Zamboni, D. S. (2020). Inflammasomes are Activated in Response to SARS-COV-2 Infection and are Associated with COVID-19 Severity in Patients. Journal of Experimental Medicine, 218(3),1707.
Rothan, H. A. and Byrareddy, S. N. (2020). The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity, 102433. https://doi.org/10.1016/j.jaut.2020.102433
Satis, H., Özger, H. S., Yıldız, P. A., Hızel, K., Gulbahar, Ö., Erbaş, G. and Tufan, A. (2021). Prognostic Value of Interleukin18 and its Association with Other Inflammatory Markers and Disease severity in COVID-19, Cytokine, 137,155-302. https://doi.org/10.1016/j.cyto.2020.155302
Sohrabi, C., Alsafi, Z., Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C. and Agha, R. (2020). Novel Coronavirus (COVID-19), International Journal of Surgery,76, 71–76. https://doi.org/10.1016/j.ijsu.2020.02.034
Sun, DW. Zhang, D., Tian, R. H., Li, Y., Wang, Y. S. and Guo, L. (2020). The Underlying Changes and Predicting Role of Peripheral Blood Inflammatory Cells in Severe COVID-19 Patients, Clinical chemistry acta, 508, 122-129. https://doi.org/10.1016/j.cca.2020.05.027
Wang, D. (2020). Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China, Jama, 21, 103-111. https://doi.org/10.1001/jama.2020.1585
World Health Organization, (2020). Coronavirus Disease (COVID-19). Weekly Epidemiological Update. Geneva, Switzerland: WHO. Retrieved November 21, 2021, from https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201005-weekly-epi-update-8.pdf.Accessed October 21, 2020.
World Health Organization, (2023). Coronavirus Disease (COVID-19). Weekly Epidemiological Update. Geneva, Switzerland: WHO. Retrieved November 21, 2021, from https://www.who.int/docs/defaultsource/coronaviruse/situationreports/20201005-weekly-epi-update-8.pdf. Accessed October 21, 2020.
Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Hu, Y., …Zhang, Y. (2020). Complete Genome Characterisation of a Novel Coronavirus Associated with Severe Human Respiratory Disease in Wuhan, China. Biology Review, 211-221. https://doi.org/10.1101/2020.01.24.919183
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C. Wang, F. (2020). Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome, Lancet Respiratory Medicine, 8(4), 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
Zhang, G., Zhang,J. and Wang. B. (2020). Analysis of Clinical Characteristics and Laboratory Findings of 95 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China, a Retrospective Analysis, Respiratory Research, 21(1), 191-8. https://doi.org/10.1186/s12931-020-01338-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
